Menu Close

Trending

Why reshoring drug production means embracing continuous manufacturing
Clariness, DailyBreath partner to drive recruitment in asthma trials
J&J says it will stop selling all talc products next year
Cumulus’ gamified dry EEG system tops lab monitoring in trial
Dismay as UK ‘drags its heels’ on AZ’s COVID antibody Evusheld

Insights

Video 2a 29_06_2018 no player

ASCO 2018/ ASCO 2018/ Insights/ Oncology/ Video

Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success

, , , , , , , , 0 Comment

Gary Hendler, chairman and CEO of EMEA region for Eisai, talked to Richard Staines at pharmaphorum about findings

X
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success
https://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
RP WP Jan017

Cancer/ Clinical/ Insights/ Oncology/ White Papers/ Whitepapers

From promise to practice: immuno-oncology in action – the new frontier in cancer treatment

0 Comment

Immuno-oncology therapies that harness the body’s own defences to fight off tumours are widely acknowledged as the new

X
From promise to practice: immuno-oncology in action – the new frontier in cancer treatment
https://pharmaphorum.com/whitepapers/from-promise-to-practice-immuno-oncology-in-action-the-new-frontier-in-cancer-treatment/

Login

CONTINUE TO SITE >
X
Close in 10 seconds